Martin Shkreli fails to overturn lifetime pharma ban — again; Daiichi Sankyo and ViGeneron re-up eye disease deal
Martin Shkreli has once again been unable to convince a judge to overturn his lifetime pharma industry ban.
Shkreli had attempted to put the ban on hold while he appealed a 2020 conviction regarding his activities related to Daraprim, but judge Denise Cote of the Southern District of New York was not swayed. Cote is the same judge who handed down the original ban in January and upheld it a few weeks later.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.